Health
Zymeworks Announces First Patient Dosed In Phase 1 Clinical Trial Evaluating ZW191 In Folate Receptor-⍺ Expressing Advanced Solid Tumors
(MENAFN - GlobeNewsWire - Nasdaq) Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell ...
By: menafn
- Nov 05 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS